Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
NCT ID | NCT03192345 |
Title | A First-in-human Study of the Safety, Pharmacokinetics, Pharmacodynamics and Anti-tumor Activity of SAR439459 Monotherapy and Combination of SAR439459 and REGN2810 in Patients With Advanced Solid Tumors |
Recruitment | Completed |
Gender | both |
Phase | Phase I |
Variant Requirements | No |
Sponsors | Sanofi |
Indications | |
Therapies | |
Age Groups: | adult | senior |
Covered Countries | USA | NLD | ITA | GBR | FRA | EST | ESP | DEU | CAN | BEL | AUS |
Facility | Status | City | State | Zip | Country | Details |
---|---|---|---|---|---|---|
The University of Kansas Clinical Research Center Site Number : 8400004 | Fairway | Kansas | 66205 | United States | Details | |
Massachusetts General Hospital Site Number : 8400001 | Boston | Massachusetts | 02114 | United States | Details | |
Dana Farber Cancer Institute Site Number : 8400101 | Boston | Massachusetts | 02115 | United States | Details | |
Duke University Medical Center Site Number : 8400008 | Durham | North Carolina | 27710 | United States | Details | |
Tennessee Oncology, PLLC Site Number : 8400006 | Nashville | Tennessee | 37203 | United States | Details | |
Mary Crowley Cancer Research Center Site Number : 8400003 | Dallas | Texas | 75230 | United States | Details | |
Investigational Site Number : 0360002 | Heidelberg West | Victoria | 3081 | Australia | Details | |
Investigational Site Number : 0360001 | Melbourne | Victoria | 3000 | Australia | Details | |
Investigational Site Number : 0560001 | Leuven | 3000 | Belgium | Details | ||
Investigational Site Number : 1240003 | Calgary | Alberta | T2N 4N2 | Canada | Details | |
Investigational Site Number : 1240001 | Toronto | Ontario | M5G 2M9 | Canada | Details | |
Investigational Site Number : 1240002 | Montreal | Quebec | H3T 1E2 | Canada | Details | |
Investigational Site Number : 2330001 | Tallinn | 13419 | Estonia | Details | ||
Investigational Site Number : 2500002 | Marseille | 13385 | France | Details | ||
Investigational Site Number : 2500003 | Nantes | 44093 | France | Details | ||
Investigational Site Number : 2500005 | Nantes | 44093 | France | Details | ||
Investigational Site Number : 2500001 | Villejuif | 94800 | France | Details | ||
Investigational Site Number : 2760001 | Essen | 45122 | Germany | Details | ||
Investigational Site Number : 2760003 | Hannover | 30625 | Germany | Details | ||
Investigational Site Number : 3800003 | Rozzano | Milano | 20089 | Italy | Details | |
Investigational Site Number : 3800001 | Milano | 20133 | Italy | Details | ||
Investigational Site Number : 3800002 | Milano | 20141 | Italy | Details | ||
Investigational Site Number : 4100001 | Seoul | Seoul-teukbyeolsi | 03080 | Korea, Republic of | Details | |
Investigational Site Number : 4100002 | Seoul | Seoul-teukbyeolsi | 138-736 | Korea, Republic of | Details | |
Investigational Site Number : 5280001 | Rotterdam | 3015 GD | Netherlands | Details | ||
Investigational Site Number : 5280002 | Utrecht | 3584 CX | Netherlands | Details | ||
Investigational Site Number : 7240002 | Barcelona | Barcelona [Barcelona] | 08003 | Spain | Details | |
Investigational Site Number : 7240001 | Barcelona | Barcelona [Barcelona] | 08035 | Spain | Details | |
Investigational Site Number : 7240003 | Madrid / Madrid | Madrid, Comunidad De | 28040 | Spain | Details | |
Investigational Site Number : 7240004 | Madrid / Madrid | Madrid, Comunidad De | 28050 | Spain | Details | |
Investigational Site Number : 7240005 | Pamplona | Navarra | 31008 | Spain | Details | |
Investigational Site Number : 1580002 | Tainan | 704 | Taiwan | Details | ||
Investigational Site Number : 8260001 | Glasgow | Central Bedfordshire | G12 0YN | United Kingdom | Details | |
Investigational Site Number : 8260002 | Cardiff | Vale Of Glamorgan, The | CF14 2TL | United Kingdom | Details |